Results 101 to 110 of about 4,874 (174)

Structures of New World mammarenavirus glycoproteins as targets for antibody-mediated neutralization. [PDF]

J Virol
Taylor LJ, Helguera G, Maruyama J, Rodriguez JA.   +3 more
europepmc   +1 more source

B cell immunity to the Lassa virus glycoprotein is a correlate of vaccination-induced virus control in mice. [PDF]

Nat Commun
Abreu-Mota T, Marx AF, Winterberg D, Tintignac K, Fixemer J, Geier F, Brodmann N, Seven C, Reichmuth C, Kastner AL, Lu M, Bonilla WV, Dimitrova M, Sahin M, Zimmer G, Peipp M, Pinschewer DD.   +16 more
europepmc   +1 more source

Lassa and Mopeia viruses produce different RIG-I-activating RNA in the absence of a functional viral exoribonuclease domain. [PDF]

J Virol
Noy K, Legendre R, Croze S, Najburg V, Fernandez R, Lucifora J, Lachuer J, Baize S, Komarova AV, Mateo M.   +9 more
europepmc   +1 more source

Chronic infection perturbs the affinity hierarchy of antiviral B cells. [PDF]

Proc Natl Acad Sci U S A
Dimitrova M, Abreu-Mota T, Fixemer J, Bonilla WV, Marx AF, Lu M, Tintignac K, Kastner AL, Ertuna YI, Florova M, Ciancaglini M, Narr K, Stauffer K, Roux J, Demougin P, Wagner I, Merkler D, Pinschewer DD.   +17 more
europepmc   +1 more source

Ending Lassa neglect: the urgent case for a licensed vaccine. [PDF]

Ann Med Surg (Lond)
Qureshi AA, Ullah F, Fatima A, Saeed MZ, Mahmood H, Mwape C.   +5 more
europepmc   +1 more source

Development and protective evaluation of mRNA vaccines encoding the glycoprotein precursor of lymphocytic choriomeningitis virus. [PDF]

Virus Res
Lyu Y, Liu J, Qiao Y, Liu M, Yang Y, Li J, Xie Y.   +6 more
europepmc   +1 more source

Arenavirus: A fatal outcame

VIRUS Reviews & Research, 2001
T. L. M. Coimbra, R. N. Santos, I. B. Ferreira, D. M. Fialho, E. S. Mello, L. M. H. L. Ferreira, E. L. B. Chamelet   +6 more
openaire   +1 more source

Lymphocytic Choriomeningitis Virus Seroprevalence in a Cohort of German Forestry Workers. [PDF]

Viruses
Mehl C, Schmidt-Chanasit J, Becker-Ziaja B, Werdermann S, Niederstraßer O, Böhmer MM, Ulrich RG.   +6 more
europepmc   +1 more source

Combining local cytokine delivery and systemic immunization with recombinant artLCMV boosts antitumor efficacy in several preclinical tumor models. [PDF]

Oncoimmunology
Pojar K, Reckendorfer D, Strauss J, Szaffich S, Ahmadi-Erber S, Schippers T, Berraondo P, Orlinger KK, Raguz J, Lauterbach H.   +9 more
europepmc   +1 more source

Going wild: prioritizing experimental models of rodent-borne viruses to decode zoonotic spillover and pandemic risk. [PDF]

J Virol
Honce R, Botten J.
europepmc   +1 more source